Skip to main content
. 2018 Apr 25;10(5):531. doi: 10.3390/nu10050531
NAFLD Non-Alcoholic Fatty Liver Disease
T2DM Type 2 Diabetes Mellitus
HOMA IR Homeostasis Model Assessment Index of Insulin Resistance
H&E Hematoxylin and eosin
NRF2 NF-E2-related factor-2
EA Ellagic acid
GK Goto Kakizaki
HIF-α Hypoxia-inducible factor-α
ROS Reactive oxygen species
TG Triglycerides
TC Total cholesterol
oGTT Oral Glucose Tolerance Test
ITT Insulin Tolerance Test
kITT Glucose disappearance rate
HOMA Homeostasis model assessment
NAS NAFLD activity score
DHE Dihydroethidium
SBP Systolic blood pressure
Ach Acetylcholine
p47phox NADPH oxidase p47phox
SOD2 Superoxide dismutase-2
NOAEL No Observed Adverse Effect Level
PE Phenylephrine